The role of HB-donor groups in the heterocyclic polar fragment of H 3-antagonists.: I. Synthesis and biological assays

Farmaco

Volumn 58, Issue 9, 2003, Pages 891-899

  Zuliani, Valentina ^a   Bordi, Fabrizio ^a   Rivara, Mirko ^a   Silva, Claudia ^a   Vacondio, Federica ^a   Morini, Giovanni ^a   Rivara, Silvia ^a   Barocelli, Elisabetta ^a   Ballabeni, Vigilio ^a   Bertoni, Simona ^a   Magnanini, Francesca ^a   Plazzi, Pier Vincenzo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

2 Aminobenzimidazole; H3 receptor antagonists; Histamine; Polar group

Indexed keywords

2 AMINOBENZOTHIAZOLE; 2 THIOBENZIMIDAZOLE; 2 THIOBENZOTHIAZOLE; 2 [3 [IMIDAZOL 4(5) YL]PROPYLAMINO]BENZOTHIAZOLE; 2 [3 [IMIDAZOL 4(5) YL]PROPYLTHIO]BENZIMIDAZOLE; 2 [3 [IMIDAZOL 4(5) YL]PROPYLTHIO]BENZOTHIAZOLE; CARBENE; HETEROCYCLIC AMINE; HISTAMINE H3 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; N METHYL 2 [2 [IMIDAZOL 4(5) YL]ETHYLTHIO] 4 PHENYLIMIDAZOLE; N METHYL 2 [3 [IMIDAZOL 4(5) YL]PROPYLTHIO] 4 PHENYLIMIDAZOLE; UNCLASSIFIED DRUG;

ARTICLE; BEHAVIOR; BINDING AFFINITY; BINDING SITE; BIOASSAY; DRUG SYNTHESIS; HYDROGEN BOND; METHYLATION; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 0141676084     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(03)00147-2     Document Type: Article

References (51)

1. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.-C., Shankley N.P., Young J.M., Schunack W., Levi R., Hass H.L. International union of pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49:1997;253-278.
2. Nakamura T., Itadani H., Hidaka Y., Ohta M., Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Commun. 279:2000;615-620.
3. Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. Molecular cloning and characterization of novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275:2000;36781-36786.
4. 3) of histamine receptor. Nature. 302:1983;832-837.
5. 3-receptors. Neuroscience. 15:1985;553-562.
6. 3-receptor. Neuroscience. 23:1987;149-157.
7. 3-heteroreceptors. Fundam. Clin. Pharmacol. 8:1994;128-137.
8. 3-Receptor, Naunyn-Schmiedburg's. Arch. Pharmacol. 346:1992;46-50.
9. 3-receptor subtypes. Br. J. Pharmacol. 107:1992;919-923.
10. 3-receptors. J. Neural. Transm. 93:1993;1-10.
11. 3-receptor mediated inhibition of serotonin release in the rat brain cortex. Arch. Pharmacol. 337:1988;588-590.
12. Smith R.P.J.M., Mulder A.H. Inhibiting effects of histamine on the release of serotonin and noradrenaline from rat brain slices. Neurochem. Int. 18:1991;215-220.
13. 3-receptor agonists and antagonists. Trends Pharmacol. Sci. 19:1998;177-183.
14. 3 receptor regulates histamine neurons in brain. Nature. 408:2000;860-864.
15. Panula P., Rinne J., Kuokkanen K., Eriksson K.S., Sallmen T., Kalimo H., Relya M. Neuronal histamine deficit in Alzheimer's disease. Neuroscience. 82:1998;993-997.
16. 3-receptors. Nature. 327:1987;117-123.
17. 3-receptor. Eur. J. Med. Chem. 27:1992;511-517.
18. 3-receptor antagonists. Eur. J. Pharm. Sci. 13:2001;249-259.
19. 3-receptor antagonists. Arch. Pharm. Pharm. Med. Chem. 331:1998;395-404.
20. 3-receptor antagonists. J. Med. Chem. 42:1999;903-909.
21. Gliatech Inc.: press release November 22, 1999; http://www.gliatech.com/news/news.cfm .
22. 3-receptor antagonist. J. Pharmacol. Exp. Ther. 287:1998;658-666.
23. 3-receptor antagonists. Bioorg. Med. Chem. Lett. 4:1994;2907-2912.
24. 3-receptor antagonists with improved in vivo potency. Die Pharmazie. 55:2000;83-86.
25. 3-receptor antagonists with high in vitro and oral in vivo activity. J. Med. Chem. 5:1996;1157-1163.
26. 3-receptor antagonists. Bioorg. Med. Chem. Lett. 9:1999;3103-3108.
27. 3-receptor antagonists. Bioorg. Med. Chem. Lett. 9:1999;1825-1830.
28. 3-receptor antagonists. Bioorg. Med. Chem. Lett. 10:2002;425-432.
29. 3-receptor. Recept. Biochem. Methodol. 16:1992;57-72.
30. 3-Receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles. J. Med. Chem. 40:1997;2571-2578.
31. 3-receptor affinity. Eur. J. Med. Chem. 30:1995;881-889.
32. 3-antagonists with imidazole and imidazoline polar groups. Il Farmaco. 55:2000;27-34.
33. 3-antagonists: from thioperamide to thioperamide unrelated imidazole derivatives. Il Farmaco. 52:1997;463-469.
34. 3-antagonists: ex vivo binding study in rats. Inflamm. Res. 51:2002;S55-S56.
35. 3-antagonists, J. Med. Chem., submitted.
36. 2 receptor histamine antagonists. J. Med. Chem. 31:1988;656-671.
37. 3-receptors in guinea-pig. Agents Actions. 38:1993;158-164.
38. S. Jegham, T.A. Purcell, G. Defosse, L. Even, Derives de benzimidazole, leur preparation et leur application en therapeutique, Fr. Demande (1996) FR 2731707.
39. Vollinga R.C., Menge W.M.P.B., Timmerman H. A new convenient route for the synthesis of 4(5)-(ω-aminoalkyl)-1H-imidazoles. Recl. Trav. Chim. Pays-Bas. 112:1993;123-125.
40. 2-receptor antagonists: ranitidine analogues containing 2-amino-5(6)-substituted-benzimidazole moieties. Eur. J. Med. Chem.-Chim. Ther. 21:1986;391-395.
41. Woods G.F., Sanders H. Studies in pyrane chemistry. J. Am. Chem. Soc. 68:1946;2483-2485.
42. Kivits G.A.A., Hora J. A convenient preparation of 3-(1H-imidazol-4-yl)propanol. J. Heterocycl. Chem. 12:1975;577.
43. Overberger C.G., Vorchheimer N. Imidazole-containing polymers. Synthesis and polymerization of the monomer 4(5)-vinylimidazole. J. Am. Chem. Soc. 85:1963;951-955.
44. Kjellin G., Sandstrom J. Tautomeric cyclic thiones. III. Preparation of N- and S-methyl derivatives of some azoline 2-thiones. Acta Chem. Scand. 23/8:1969;2879-2887.
45. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
46. Furchgott R.F. The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. Blanschko E., Muscholl E. Handbook of Experimental Pharmacology. 33:1972;283-335 Springer, Berlin.
47. 3 receptors. Eur. J. Pharmacol. 433:2001;141-150.
48. BH+ values of 2-aminothiazoles and of some model imines. J. Chem. Soc., Perkin Trans. II. 2:1982;535-538.
49. Foye W., Lo J.-R. Metal-binding abilities of antibacterial heterocyclic thiones. J. Pharm. Sci. 61:1972;1209-1212.
50. 2-antagonist derivatives containing 5(6)-substituted-2-aminobenzimidazole moiety. Ann. Chim. 79:1989;81-86.
51. Van Rossum J.M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. 143:1963;299-330.